Alpha Cubed Cuts MetLife Stake by 5.3% as Q3 EPS Tops Estimates

METMET

Alpha Cubed Investments cut its MetLife stake by 5.3%, selling 7,476 shares to hold 132,858 shares valued at $10.94M. MetLife posted Q3 EPS of $2.37, beating estimates by $0.07 on $12.46B revenue and declared a $0.5675 dividend payable March 10, ex-dividend February 3.

1. Q4 Earnings Outlook and Revenue Drivers

MetLife is projected to deliver a year-over-year increase in fourth-quarter earnings per share, with consensus estimates calling for EPS of approximately 2.50, up from 2.37 in the prior year period. Total revenues are expected to climb by around 3% to near 12.8 billion, driven by a 5% growth in life and accident premiums and a 7% rise in fee income from retirement and savings products. International operations, particularly in Asia and Latin America, are forecast to contribute an incremental 150 million in pre-tax income, reflecting improved underwriting margins and favorable currency translation effects.

2. Institutional Investor Adjustments

According to the latest Form 13F filings, Alpha Cubed Investments LLC reduced its MetLife holdings by 5.3%, selling 7,476 shares and ending the quarter with 132,858 shares valued at 10.9 million. Valley Wealth Managers Inc. modestly increased its position by 1.7% to 289,713 shares (23.9 million), while Golden State Wealth Management LLC more than doubled its stake to 1,368 shares (113 thousand). Cloud Capital Management LLC initiated a new position valued at 71 thousand, and Great Lakes Advisors LLC entered with a 310 thousand investment. Hedge funds and institutional investors now collectively hold roughly 95% of MetLife’s outstanding shares.

3. Dividend Policy and Analyst Ratings

MetLife’s board recently approved a quarterly dividend of 0.5675 per share, payable March 10 to holders of record on February 3, representing a 2.9% yield and a 42.8% payout ratio on trailing earnings. The company’s dividend consistency underscores its strong capital generation and 21.0% return on equity in the last reported quarter. On the analyst front, two firms maintain a Strong Buy stance, nine recommend Buy and two have Hold ratings, yielding a consensus target equivalent to 95.27. Recent target adjustments include reductions by Keefe, Bruyette & Woods from 92.00 to 90.00 and by UBS from 95.00 to 94.00, while Morgan Stanley continues to advocate an overweight view with a 101.00 objective.

Sources

ZDZ